AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,640,892 | -1.9% | 80,711 | +0.9% | 0.45% | -1.3% |
| Q2 2023 | $5,748,800 | -51.8% | 80,000 | -58.6% | 0.45% | -56.7% |
| Q1 2023 | $11,922,066 | -27.5% | 193,289 | -9.4% | 1.04% | -36.0% |
| Q4 2022 | $16,450,981 | +90.1% | 213,289 | +9.9% | 1.63% | +38.6% |
| Q3 2022 | $8,656,000 | -6.8% | 194,000 | -20.0% | 1.18% | -18.7% |
| Q2 2022 | $9,288,000 | -7.5% | 242,500 | 0.0% | 1.45% | +5.1% |
| Q1 2022 | $10,037,000 | +9.6% | 242,500 | 0.0% | 1.38% | -29.5% |
| Q4 2021 | $9,162,000 | +11.2% | 242,500 | -3.0% | 1.95% | +61.5% |
| Q3 2021 | $8,240,000 | -51.1% | 250,000 | 0.0% | 1.21% | -51.5% |
| Q2 2021 | $16,865,000 | +19.1% | 250,000 | 0.0% | 2.50% | -22.6% |
| Q1 2021 | $14,155,000 | -30.5% | 250,000 | 0.0% | 3.22% | -8.2% |
| Q4 2020 | $20,368,000 | +14.3% | 250,000 | 0.0% | 3.51% | +1.5% |
| Q3 2020 | $17,813,000 | -13.4% | 250,000 | 0.0% | 3.46% | -18.8% |
| Q2 2020 | $20,570,000 | – | 250,000 | – | 4.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |